FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
12/19/2023
Back to search
Official data from USPTO
ELUCIREM GADOPICLENOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/19/2023
Trademark type
Combined
Nice classes
5, 10
Filing date
06/10/2022
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/22/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
FR
Examiner
HUDSON, TAMARA BREE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized navy blue wording "ELUCIREM" above the smaller stylized navy blue wording "GADOPICLENOL". All of the wording is to the right of three concentric incomplete circles, with each being made up of smaller shaded circles that grow in size from the top of the incomplete circles to the bottom. The circles start as the color yellow at the top, then fade to the color orange in the middle, fading further to the color purple at the bottom.
Holders and representatives
Holders
GUERBET
Representatives
Dianne M. Smith-Misemer Hovey Williams LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Contrast products used in the field of magnetic resonance imaging (MRI)
Class 10
Medical device intended for injection of pharmaceutical products for medical use
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/28/2023
FIMP
FINAL DISPOSITION PROCESSED
11/28/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/17/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2023
RFNT
REFUSAL PROCESSED BY IB
02/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2023
RFRR
REFUSAL PROCESSED BY MPU
01/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2022
CNRT
NON-FINAL ACTION WRITTEN
11/02/2022
DOCK
ASSIGNED TO EXAMINER
10/27/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2022
Continuous trademark protection
Get notified about every new filing that threatens ELUCIREM GADOPICLENOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.